Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
If your order arrives damaged, defective, or with missing items, please contact our support team with your order details and any relevant evidence
04 Flushing or chest tightness during IV Clinicians typically slow the infusion rate because faster IV NAD+ rates are the most commonly reported driver of acute side effects
Key takeaways Regulatory Status: As of April 2026, BPC-157 is classified as a Category 2 bulk drug substance by the FDA prohibited in compounding under Section 503A and 503B
As with all natural recovery supplements, periodic breaks and medical oversight are encouraged
US$ 29.12
US$ 26.83
US$ 29.73
US$ 23.67
